Bielawski J - Search Results

1

Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry.

Bielawski J, Szulc ZM, Hannun YA, Bielawska A. Bielawski J, et al. Methods. 2006 Jun;39(2):82-91. doi: 10.1016/j.ymeth.2006.05.004. Methods. 2006. PMID: 16828308

2

Quantitative measurement of different ceramide species from crude cellular extracts by normal-phase high-performance liquid chromatography coupled to atmospheric pressure ionization mass spectrometry.

Pettus BJ, Kroesen BJ, Szulc ZM, Bielawska A, Bielawski J, Hannun YA, Busman M. Pettus BJ, et al. Among authors: bielawski j. Rapid Commun Mass Spectrom. 2004;18(5):577-83. doi: 10.1002/rcm.1373. Rapid Commun Mass Spectrom. 2004. PMID: 14978803

3

Novel analogs of D-e-MAPP and B13. Part 2: signature effects on bioactive sphingolipids.

Bielawska A, Bielawski J, Szulc ZM, Mayroo N, Liu X, Bai A, Elojeimy S, Rembiesa B, Pierce J, Norris JS, Hannun YA. Bielawska A, et al. Among authors: bielawski j. Bioorg Med Chem. 2008 Jan 15;16(2):1032-45. doi: 10.1016/j.bmc.2007.08.032. Epub 2007 Aug 24. Bioorg Med Chem. 2008. PMID: 17881234 Free PMC article.

4

Comprehensive quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry.

Bielawski J, Pierce JS, Snider J, Rembiesa B, Szulc ZM, Bielawska A. Bielawski J, et al. Methods Mol Biol. 2009;579:443-67. doi: 10.1007/978-1-60761-322-0_22. Methods Mol Biol. 2009. PMID: 19763489

5

Blood sphingolipidomics in healthy humans: impact of sample collection methodology.

Hammad SM, Pierce JS, Soodavar F, Smith KJ, Al Gadban MM, Rembiesa B, Klein RL, Hannun YA, Bielawski J, Bielawska A. Hammad SM, et al. Among authors: bielawski j. J Lipid Res. 2010 Oct;51(10):3074-87. doi: 10.1194/jlr.D008532. Epub 2010 Jul 21. J Lipid Res. 2010. PMID: 20660127 Free PMC article.

6

Sphingolipid analysis by high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS).

Bielawski J, Pierce JS, Snider J, Rembiesa B, Szulc ZM, Bielawska A. Bielawski J, et al. Adv Exp Med Biol. 2010;688:46-59. doi: 10.1007/978-1-4419-6741-1_3. Adv Exp Med Biol. 2010. PMID: 20919645 Review.

7

Tailoring structure-function and targeting properties of ceramides by site-specific cationization.

Szulc ZM, Bielawski J, Gracz H, Gustilo M, Mayroo N, Hannun YA, Obeid LM, Bielawska A. Szulc ZM, et al. Among authors: bielawski j. Bioorg Med Chem. 2006 Nov 1;14(21):7083-104. doi: 10.1016/j.bmc.2006.07.016. Epub 2006 Aug 17. Bioorg Med Chem. 2006. PMID: 16919460

8

Golgi fragmentation is associated with ceramide-induced cellular effects.

Hu W, Xu R, Zhang G, Jin J, Szulc ZM, Bielawski J, Hannun YA, Obeid LM, Mao C. Hu W, et al. Among authors: bielawski j. Mol Biol Cell. 2005 Mar;16(3):1555-67. doi: 10.1091/mbc.e04-07-0594. Epub 2005 Jan 12. Mol Biol Cell. 2005. PMID: 15647381 Free PMC article.

9

Regulation of the sphingosine-recycling pathway for ceramide generation by oxidative stress, and its role in controlling c-Myc/Max function.

Sultan I, Senkal CE, Ponnusamy S, Bielawski J, Szulc Z, Bielawska A, Hannun YA, Ogretmen B. Sultan I, et al. Among authors: bielawski j. Biochem J. 2006 Jan 15;393(Pt 2):513-21. doi: 10.1042/BJ20051083. Biochem J. 2006. PMID: 16201965 Free PMC article.

10

Involvement of sphingolipids in apoptin-induced cell killing.

Liu X, Zeidan YH, Elojeimy S, Holman DH, El-Zawahry AM, Guo GW, Bielawska A, Bielawski J, Szulc Z, Rubinchik S, Dong JY, Keane TE, Tavassoli M, Hannun YA, Norris JS. Liu X, et al. Among authors: bielawski j. Mol Ther. 2006 Nov;14(5):627-36. doi: 10.1016/j.ymthe.2006.07.001. Epub 2006 Aug 22. Mol Ther. 2006. PMID: 16926120 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

327 results

Search Page